Edition:
United States

Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

136.70DKK
19 Mar 2019
Change (% chg)

-- (--)
Prev Close
kr.136.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
183,845
52-wk High
kr.214.80
52-wk Low
kr.117.75

Chart for

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)

Overall

Beta: 1.66
Market Cap(Mil.): kr.4,379.70
Shares Outstanding(Mil.): 32.31
Dividend: --
Yield (%): --

Financials

  BAVA.CO Industry Sector
P/E (TTM): -- 37.68 41.05
EPS (TTM): -13.90 -- --
ROI: -16.66 12.63 12.19
ROE: -18.11 13.61 13.29

Earnings vs. Estimates